Amit Singh1, Ketan Pajni2, Inusha Panigrahi3, Navdeep Dhoat4, Sabyasachi Senapati2, Preeti Khetarpal5. 1. Laboratory for Reproductive and Developmental Disorders, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India. 2. Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India. 3. Department of Paediatric Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India. 4. Department of Paediatric Surgery, All India Institute of Medical Sciences, Bathinda, 151001, India. 5. Laboratory for Reproductive and Developmental Disorders, Department of Human Genetics and Molecular Medicine, School of Health Sciences, Central University of Punjab, Bathinda, 151401, India. preetikhetarpal@cup.edu.in.
Abstract
PURPOSE: In this review, epi/genetic mutations of IGF-axis components associated with growth disorders have been summarized alongwith assessment of relevant diagnostic and therapeutic technology through patent literature. METHODOLOGY: PROSPERO protocol registration CRD42021279468. For scientific literature search Literature databases (PubMed, EMBASE, ScienceDirect, and Google Scholar) were queried using the appropriate syntax. Various filters were applied based on inclusion and exclusion criteria. Search results were further refined by two authors for finalizing studies to be included in this synthesis. For patent documents search Patent databases (Patentscope and Espacenet) were queried using keywords: IGF or IGFBP. Filters were applied according to International Patent Classification (IPC) and Cooperative Patent Classification (CPC). Search results were reviewed by two authors for inclusion in the patent landscape report. RESULTS: For scientific literature analysis, out of 545 search results, 196 were selected for review based on the inclusion criteria. For Patent literature search, out of 485 results, 37 were selected for this synthesis. CONCLUSION: Dysregulation of IGF-axis components leads to various abnormalities and their key role in growth and development suggests epi/mutations or structural defects among IGF-axis genes can be associated with growth disorders and may explain some of the idiopathic short stature cases. Trend of patent filings indicate advent of recombinant technology for therapeutics.
PURPOSE: In this review, epi/genetic mutations of IGF-axis components associated with growth disorders have been summarized alongwith assessment of relevant diagnostic and therapeutic technology through patent literature. METHODOLOGY: PROSPERO protocol registration CRD42021279468. For scientific literature search Literature databases (PubMed, EMBASE, ScienceDirect, and Google Scholar) were queried using the appropriate syntax. Various filters were applied based on inclusion and exclusion criteria. Search results were further refined by two authors for finalizing studies to be included in this synthesis. For patent documents search Patent databases (Patentscope and Espacenet) were queried using keywords: IGF or IGFBP. Filters were applied according to International Patent Classification (IPC) and Cooperative Patent Classification (CPC). Search results were reviewed by two authors for inclusion in the patent landscape report. RESULTS: For scientific literature analysis, out of 545 search results, 196 were selected for review based on the inclusion criteria. For Patent literature search, out of 485 results, 37 were selected for this synthesis. CONCLUSION: Dysregulation of IGF-axis components leads to various abnormalities and their key role in growth and development suggests epi/mutations or structural defects among IGF-axis genes can be associated with growth disorders and may explain some of the idiopathic short stature cases. Trend of patent filings indicate advent of recombinant technology for therapeutics.
Authors: Inma Castilla-Cortazar; Julieta Rodriguez de Ita; Gabriel Amador Aguirre; Fabiola Castorena-Torres; Jesús Ortiz-Urbina; Mariano García-Magariño; Rocío García de la Garza; Carlos Diaz Olachea; Martha Irma Elizondo Leal Journal: Am J Med Sci Date: 2017-02-04 Impact factor: 2.378
Authors: Aldona Kasprzak; Wojciech Kwasniewski; Agnieszka Adamek; Anna Gozdzicka-Jozefiak Journal: Mutat Res Rev Mutat Res Date: 2016-09-04 Impact factor: 5.657
Authors: Riia K Junnila; John J Kopchick; Edward O List; Darlene E Berryman; John W Murrey Journal: Nat Rev Endocrinol Date: 2013-04-16 Impact factor: 43.330